Article Details

Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application ... - BioPharmaJournal

Retrieved on: 2022-09-02 16:58:30

Tags for this article:

Click the tags to see associated articles and topics

Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application ... - BioPharmaJournal. View article details on HISWAI: https://biopharmajournal.com/2022/09/02/minerva-neurosciences-inc-nasdaq-nerv-submits-new-drug-application-for-roluperidone-in-treating-negative-schizophrenia-symptoms/

Excerpt

Minerva Neurosciences Inc (NASDAQ: NERV) has announced the submission of a New Drug Application to the US FDA for roluperidone in treating ...

Article found on: biopharmajournal.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up